|
G |
Acan |
aggrecan |
multiple interactions |
ISO |
oxymatrine inhibits the reaction [IL1B protein results in decreased expression of ACAN protein] |
CTD |
PMID:37196756 |
|
NCBI chr 1:132,981,582...133,044,416
Ensembl chr 1:132,981,582...133,043,627
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions |
ISO |
oxymatrine inhibits the reaction [sodium arsenite results in increased expression of ACTA2 protein] oxymatrine inhibits the reaction [SNHG6 results in increased expression of ACTA2 protein] |
CTD |
PMID:33241020 PMID:35785413 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Adamts5 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
multiple interactions |
ISO |
oxymatrine inhibits the reaction [IL1B protein results in increased expression of ADAMTS5 protein] |
CTD |
PMID:37196756 |
|
NCBI chr11:25,000,627...25,047,205
Ensembl chr11:25,000,637...25,047,205
|
|
G |
Atp2a1 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 |
multiple interactions |
ISO |
oxymatrine inhibits the reaction [sodium arsenite results in decreased expression of ATP2A1 mRNA] |
CTD |
PMID:33241020 |
|
NCBI chr 1:181,026,606...181,044,859
Ensembl chr 1:181,026,608...181,044,838
|
|
G |
Atp2a2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
multiple interactions |
ISO |
[oxymatrine co-treated with sodium arsenite] results in decreased expression of ATP2A2 protein |
CTD |
PMID:33241020 |
|
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
ISO |
oxymatrine analog inhibits the reaction [TNF protein results in decreased expression of BAX protein] oxymatrine results in increased expression of BAX protein |
CTD |
PMID:34459104 PMID:39419199 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
ISO |
oxymatrine analog inhibits the reaction [TNF protein results in increased expression of BCL2 protein] oxymatrine results in decreased expression of BCL2 protein |
CTD |
PMID:34459104 PMID:39419199 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Capn2 |
calpain 2 |
increases expression multiple interactions |
ISO |
oxymatrine results in increased expression of CAPN2 protein oxymatrine promotes the reaction [sodium arsenite results in increased expression of CAPN2 protein] |
CTD |
PMID:33241020 |
|
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
|
|
G |
Casp3 |
caspase 3 |
increases cleavage |
ISO |
oxymatrine results in increased cleavage of CASP3 protein |
CTD |
PMID:39419199 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
increases cleavage |
ISO |
oxymatrine results in increased cleavage of CASP9 protein |
CTD |
PMID:39419199 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions |
EXP |
oxymatrine inhibits the reaction [arsenic trioxide results in decreased activity of CAT protein] |
CTD |
PMID:27713174 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccn2 |
cellular communication network factor 2 |
multiple interactions |
ISO |
oxymatrine inhibits the reaction [SNHG6 results in increased expression of CCN2 protein] |
CTD |
PMID:35785413 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Cdh1 |
cadherin 1 |
increases expression |
ISO |
oxymatrine results in increased expression of CDH1 protein |
CTD |
PMID:39419199 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cldn2 |
claudin 2 |
multiple interactions |
EXP |
oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of CLDN2 mRNA]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of CLDN2 protein] |
CTD |
PMID:35290143 |
|
NCBI chr X:103,459,870...103,473,794
Ensembl chr X:103,459,780...103,474,838
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions |
ISO |
oxymatrine inhibits the reaction [SNHG6 results in increased expression of COL1A1 protein] |
CTD |
PMID:35785413 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Crebbp |
CREB binding protein |
multiple interactions |
ISO |
oxymatrine inhibits the reaction [Carbon Tetrachloride results in increased expression of CREBBP mRNA] |
CTD |
PMID:18395914 |
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Ctnnb1 |
catenin beta 1 |
decreases expression |
ISO |
oxymatrine results in decreased expression of CTNNB1 protein |
CTD |
PMID:39419199 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
multiple interactions |
EXP |
oxymatrine inhibits the reaction [Lipopolysaccharides promotes the reaction [RELA protein binds to CXCL2 promoter]]; oxymatrine inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL2 mRNA] |
CTD |
PMID:23568217 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression multiple interactions decreases expression |
ISO |
oxymatrine results in increased expression of DDIT3 mRNA oxymatrine inhibits the reaction [sodium arsenite results in increased expression of DDIT3 protein]; oxymatrine promotes the reaction [sodium arsenite results in increased expression of DDIT3 mRNA] oxymatrine results in decreased expression of DDIT3 protein |
CTD |
PMID:33241020 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
ISO |
oxymatrine inhibits the reaction [SNHG6 results in increased expression of FN1 protein] |
CTD |
PMID:35785413 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP |
oxymatrine inhibits the reaction [Carbon Tetrachloride results in increased activity of GPT protein] |
CTD |
PMID:15603720 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
EXP ISO |
oxymatrine promotes the reaction [arsenic trioxide results in increased expression of HMOX1 protein] NFE2L2 protein promotes the reaction [oxymatrine promotes the reaction [IL1B protein results in increased expression of HMOX1 protein]]; oxymatrine promotes the reaction [IL1B protein results in increased expression of HMOX1 protein] |
CTD |
PMID:27713174 PMID:37196756 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
decreases expression multiple interactions |
ISO |
oxymatrine results in decreased expression of HSPA5 mRNA oxymatrine inhibits the reaction [sodium arsenite results in increased expression of HSPA5 mRNA]; oxymatrine inhibits the reaction [sodium arsenite results in increased expression of HSPA5 protein] |
CTD |
PMID:33241020 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
EXP |
oxymatrine inhibits the reaction [Carbon Tetrachloride results in decreased expression of IFNG protein] |
CTD |
PMID:15603720 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
EXP |
oxymatrine inhibits the reaction [Carbon Tetrachloride results in increased expression of IL10 protein]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL10 mRNA]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL10 protein] |
CTD |
PMID:15603720 PMID:35290143 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO EXP |
[oxymatrine co-treated with IL1B protein] results in decreased expression of NFE2L2 protein; NFE2L2 protein promotes the reaction [oxymatrine inhibits the reaction [IL1B protein results in increased expression of RELA protein]]; NFE2L2 protein promotes the reaction [oxymatrine promotes the reaction [IL1B protein results in increased expression of HMOX1 protein]]; oxymatrine inhibits the reaction [Dextran Sulfate results in increased expression of IL1B mRNA]; oxymatrine inhibits the reaction [IL1B protein results in decreased expression of ACAN protein]; oxymatrine inhibits the reaction [IL1B protein results in decreased expression of NFKBIA protein]; oxymatrine inhibits the reaction [IL1B protein results in increased abundance of Nitrites]; oxymatrine inhibits the reaction [IL1B protein results in increased expression of ADAMTS5 protein]; oxymatrine inhibits the reaction [IL1B protein results in increased expression of IL6 mRNA]; oxymatrine inhibits the reaction [IL1B protein results in increased expression of IL6 protein]; oxymatrine inhibits the reaction [IL1B protein results in increased expression of MMP13 protein]; oxymatrine inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA]; oxymatrine inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA]; oxymatrine inhibits the reaction [IL1B protein results in increased expression of RELA protein]; oxymatrine inhibits the reaction [IL1B protein results in increased expression of TNF mRNA]; oxymatrine inhibits the reaction [IL1B protein results in increased expression of TNF protein]; oxymatrine inhibits the reaction [IL1B protein results in increased secretion of LDHA protein]; oxymatrine promotes the reaction [IL1B protein results in increased expression of HMOX1 protein]; oxymatrine promotes the reaction [IL1B protein results in increased expression of NFE2L2 protein] oxymatrine analog inhibits the reaction [TNF protein results in increased expression of IL1B protein] oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B mRNA]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL1B protein] |
CTD |
PMID:23568217 PMID:34459104 PMID:35290143 PMID:37196756 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
EXP |
oxymatrine inhibits the reaction [Carbon Tetrachloride results in decreased expression of IL2 protein] |
CTD |
PMID:15603720 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO EXP |
oxymatrine inhibits the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; oxymatrine inhibits the reaction [IL1B protein results in increased expression of IL6 mRNA]; oxymatrine inhibits the reaction [IL1B protein results in increased expression of IL6 protein]; oxymatrine inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA] oxymatrine inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 mRNA]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 protein] oxymatrine analog inhibits the reaction [TNF protein results in increased expression of IL6 protein] |
CTD |
PMID:23568217 PMID:34459104 PMID:35290143 PMID:37196756 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
multiple interactions increases expression |
ISO |
oxymatrine inhibits the reaction [arsenic trioxide results in decreased localization of KCNH2 protein] oxymatrine results in increased expression of KCNH2 protein |
CTD |
PMID:23103450 |
|
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
multiple interactions |
ISO |
[oxymatrine inhibits the reaction [KEAP1 protein binds to NFE2L2 protein]] which results in increased stability of and results in increased localization of NFE2L2 protein; oxymatrine inhibits the reaction [KEAP1 protein binds to NFE2L2 protein] |
CTD |
PMID:37196756 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Ldha |
lactate dehydrogenase A |
multiple interactions |
ISO |
oxymatrine inhibits the reaction [IL1B protein results in increased secretion of LDHA protein] |
CTD |
PMID:37196756 |
|
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
multiple interactions |
ISO |
MAP2K1 protein inhibits the reaction [oxymatrine results in decreased phosphorylation of MAPK1 protein]; MAP2K1 protein inhibits the reaction [oxymatrine results in decreased phosphorylation of MAPK3 protein]; oxymatrine results in decreased phosphorylation of and results in increased stability of MAP2K1 protein |
CTD |
PMID:39419199 |
|
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions decreases phosphorylation |
ISO |
MAP2K1 protein inhibits the reaction [oxymatrine results in decreased phosphorylation of MAPK1 protein] |
CTD |
PMID:39419199 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases phosphorylation multiple interactions |
ISO |
oxymatrine results in decreased phosphorylation of MAPK3 protein MAP2K1 protein inhibits the reaction [oxymatrine results in decreased phosphorylation of MAPK3 protein] |
CTD |
PMID:39419199 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
multiple interactions |
ISO |
oxymatrine analog inhibits the reaction [TNF protein results in increased expression of MMP1 protein] |
CTD |
PMID:34459104 |
|
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mmp13 |
matrix metallopeptidase 13 |
multiple interactions |
ISO |
oxymatrine analog inhibits the reaction [TNF protein results in increased expression of MMP13 protein] oxymatrine inhibits the reaction [IL1B protein results in increased expression of MMP13 protein] |
CTD |
PMID:34459104 PMID:37196756 |
|
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
multiple interactions |
EXP |
oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MYD88 protein] |
CTD |
PMID:35290143 |
|
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
EXP ISO |
oxymatrine promotes the reaction [arsenic trioxide results in increased expression of NFE2L2 protein] [oxymatrine co-treated with IL1B protein] results in decreased expression of NFE2L2 protein; [oxymatrine inhibits the reaction [KEAP1 protein binds to NFE2L2 protein]] which results in increased stability of and results in increased localization of NFE2L2 protein; NFE2L2 protein promotes the reaction [oxymatrine inhibits the reaction [IL1B protein results in increased expression of RELA protein]]; NFE2L2 protein promotes the reaction [oxymatrine promotes the reaction [IL1B protein results in increased expression of HMOX1 protein]]; oxymatrine inhibits the reaction [KEAP1 protein binds to NFE2L2 protein]; oxymatrine promotes the reaction [IL1B protein results in increased expression of NFE2L2 protein] |
CTD |
PMID:27713174 PMID:37196756 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
oxymatrine inhibits the reaction [IL1B protein results in decreased expression of NFKBIA protein] |
CTD |
PMID:37196756 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
oxymatrine analog inhibits the reaction [TNF protein results in increased expression of NOS2 protein] oxymatrine inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA] |
CTD |
PMID:34459104 PMID:37196756 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Ocln |
occludin |
multiple interactions |
EXP |
oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of OCLN mRNA]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of OCLN protein] |
CTD |
PMID:35290143 |
|
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
|
|
G |
Ptgis |
prostaglandin I2 synthase |
increases expression |
EXP |
Oxymatrine increases expression of Ptgis protein in the heart left ventricle |
RGD |
PMID:27802898 |
RGD:401960097 |
NCBI chr 3:155,928,564...155,964,228
Ensembl chr 3:155,916,412...155,965,451
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
oxymatrine analog inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] oxymatrine inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] |
CTD |
PMID:34459104 PMID:37196756 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions decreases expression |
EXP ISO |
oxymatrine inhibits the reaction [Lipopolysaccharides promotes the reaction [RELA protein binds to CXCL2 promoter]]; oxymatrine inhibits the reaction [Lipopolysaccharides results in increased localization of RELA protein]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased phosphorylation of RELA protein] oxymatrine analog inhibits the reaction [TNF protein results in increased expression of RELA protein modified form] NFE2L2 protein promotes the reaction [oxymatrine inhibits the reaction [IL1B protein results in increased expression of RELA protein]]; oxymatrine inhibits the reaction [IL1B protein results in increased expression of RELA protein] oxymatrine results in decreased expression of RELA protein |
CTD |
PMID:23568217 PMID:34459104 PMID:35290143 PMID:37196756 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Ryr1 |
ryanodine receptor 1 |
multiple interactions increases expression |
ISO |
oxymatrine promotes the reaction [sodium arsenite results in increased expression of RYR1 mRNA] oxymatrine results in increased expression of RYR1 mRNA |
CTD |
PMID:33241020 |
|
NCBI chr 1:84,292,578...84,423,824
Ensembl chr 1:84,292,578...84,423,812
|
|
G |
Smad2 |
SMAD family member 2 |
decreases expression |
ISO |
oxymatrine results in decreased expression of SMAD2 protein |
CTD |
PMID:35785413 |
|
NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323
|
|
G |
Smad3 |
SMAD family member 3 |
multiple interactions decreases expression |
ISO |
oxymatrine inhibits the reaction [Carbon Tetrachloride results in increased expression of SMAD3 mRNA] oxymatrine results in decreased expression of SMAD3 protein |
CTD |
PMID:18395914 PMID:35785413 |
|
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
|
|
G |
Smad7 |
SMAD family member 7 |
increases expression |
ISO |
oxymatrine results in increased expression of SMAD7 mRNA |
CTD |
PMID:18395914 |
|
NCBI chr18:68,988,429...69,016,774
Ensembl chr18:68,988,429...69,016,765
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
ISO |
oxymatrine inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 protein] oxymatrine inhibits the reaction [sodium arsenite results in increased secretion of TGFB1 protein] |
CTD |
PMID:18395914 PMID:33241020 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
multiple interactions |
EXP |
oxymatrine inhibits the reaction [Carbon Tetrachloride results in increased expression of TIMP1 protein] |
CTD |
PMID:15633229 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tjp1 |
tight junction protein 1 |
multiple interactions |
EXP |
oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of TJP1 mRNA]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of TJP1 protein] |
CTD |
PMID:35290143 |
|
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
|
|
G |
Tlr9 |
toll-like receptor 9 |
multiple interactions |
EXP |
oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TLR9 protein] |
CTD |
PMID:35290143 |
|
NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO EXP |
oxymatrine inhibits the reaction [IL1B protein results in increased expression of TNF mRNA]; oxymatrine inhibits the reaction [IL1B protein results in increased expression of TNF protein]; oxymatrine inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA] oxymatrine inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF protein]; oxymatrine inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein] oxymatrine analog inhibits the reaction [TNF protein results in decreased expression of BAX protein]; oxymatrine analog inhibits the reaction [TNF protein results in increased expression of BCL2 protein]; oxymatrine analog inhibits the reaction [TNF protein results in increased expression of CXCL8 protein]; oxymatrine analog inhibits the reaction [TNF protein results in increased expression of IL1B protein]; oxymatrine analog inhibits the reaction [TNF protein results in increased expression of IL6 protein]; oxymatrine analog inhibits the reaction [TNF protein results in increased expression of MMP1 protein]; oxymatrine analog inhibits the reaction [TNF protein results in increased expression of MMP13 protein]; oxymatrine analog inhibits the reaction [TNF protein results in increased expression of NOS2 protein]; oxymatrine analog inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]; oxymatrine analog inhibits the reaction [TNF protein results in increased expression of RELA protein modified form] |
CTD |
PMID:15603720 PMID:23568217 PMID:34459104 PMID:35290143 PMID:37196756 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Vim |
vimentin |
multiple interactions decreases expression |
ISO |
oxymatrine inhibits the reaction [SNHG6 results in increased expression of VIM protein] oxymatrine results in decreased expression of VIM protein |
CTD |
PMID:35785413 PMID:39419199 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|